Fletikumab
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Target | IL20 |
| Clinical data | |
| Other names | NNC0109-0012 |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C6494H10000N1728O2050S44 |
| Molar mass | 146492.12 g·mol−1 |
Fletikumab (NNC0109-0012) (INN) is a monoclonal antibody designed for the treatment of rheumatoid arthritis that targets IL-20.
This drug was being developed by Novo Nordisk A/S until Novo ceased work in inflammation.